The recent slide in Healthways shares has led Dougherty analyst Brooks O'Neil to upgrade the wellness services provider to 'buy' from 'neutral,' a move that has lifted the stock (Ticker: HWAY) more than 6 percent in early Monday action. Of note: O'Neil didn't bump up his $12 price target.